Company Directory > CDMO > Immacule Lifesciences Pvt. Ltd.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Immacule Lifesciences Pvt. Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Immacule Lifesciences is a specialized pharmaceutical Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable products. The company provides end-to-end solutions, from formulation development and analytical services to commercial-scale manufacturing of liquid and lyophilized injectables in vials and ampoules. Founded in 2012 as a joint venture involving the Acme Group, the company operates state-of-the-art facilities in Nalagarh, Himachal Pradesh. It serves global markets with capabilities that comply with major regulatory standards, including USFDA, UK-MHRA, and ANVISA, and is actively expanding its portfolio of ANDA approvals.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:CDMO
Sub-Industry:Sterile Injectables
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$12M-$60M
Founded:2012
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Liquid injectables, Lyophilized injectables
Active Trials:0
Trial Phases:-
FDA Approvals:37
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Acme Group
Key Partnerships:Acme Formulation (Joint Venture partner), SRS Pharmaceuticals (Joint Venture partner)
COMPETITION
Position:Challenger
LEADERSHIP
Key Executives:
Vikas Sharma - Director
Viral Shah - Director
Board Members:Vikas Sharma, Viral Shah, Suchet Shyamsunder Rastogi, Rishi Aggarwal, Nirav Vikram Maniar
LINKS
Website:immacule.in
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immacule Lifesciences Pvt. Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.